Key result
Quantitative differences in MyHC expression in mouse skeletal muscle evolved at least in part through the elimination of positive-acting transcription factor binding sites.
Quantitative differences in MyHC expression in mouse skeletal muscle evolved partly through the elimination of positive-acting transcription factor binding sites.
Does not yet alter clinical muscle disorder management; extends evolutionary models of MyHC regulation but leaves applicability to humans open.
Adult fast muscle fibers express distinct myosin heavy chains (MyHC) in differing proportions, but the mechanisms underlying their differential expression remain undefined. We used a variety of in vitro and in vivo approaches to explore the contribution of transcriptional regulation to adult fast MyHC expression. Here we show that 800-1000 bp of a sequence upstream of the three mouse adult fast MyHC genes (Ia, IIb, and IId/x) are sufficient to drive muscle-specific and fiber-specific expression in vivo. We show that the upstream promoter region of the gene most abundantly expressed in mouse skeletal muscles, IIb MyHC, retains binding activity and transcriptional activation for three positive transcription factors, the serum response factor, Oct-1, and myocyte enhancer factor-2, whereas the other two genes (IIa and IId/x) have nucleotide substitutions in these sites that reduce binding and transcriptional activation. Finally, we demonstrate that regions upstream of 300 bp modulate the effects of these elements. Together, these data demonstrate that the quantitative differences in MyHC expression in mouse skeletal muscle have evolved at least in part through the elimination of positive-acting transcription factor binding sites.
No takes yet. Share an insight, caveat, or question.
Allen et al. (2005) studied this question. Transcriptional regulation of adult fast MyHC expression was evaluated on MyHC expression and transcription factor binding. Quantitative differences in MyHC expression in mouse skeletal muscle evolved at least in part through the elimination of positive-acting transcription factor binding sites.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: